First Time Loading...

MaxCyte Inc
LSE:MXCT

Watchlist Manager
MaxCyte Inc Logo
MaxCyte Inc
LSE:MXCT
Watchlist
Price: 365 GBX -0.54% Market Closed
Updated: May 25, 2024

MaxCyte Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MaxCyte Inc
Gross Profit Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
MaxCyte Inc
LSE:MXCT
Gross Profit
$36.5m
CAGR 3-Years
16%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Gross Profit
$17.2B
CAGR 3-Years
-2%
CAGR 5-Years
9%
CAGR 10-Years
11%
Danaher Corp
NYSE:DHR
Gross Profit
$25.6B
CAGR 3-Years
21%
CAGR 5-Years
23%
CAGR 10-Years
10%
Mettler-Toledo International Inc
NYSE:MTD
Gross Profit
$2.2B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
6%
Agilent Technologies Inc
NYSE:A
Gross Profit
$3.4B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
8%
IQVIA Holdings Inc
NYSE:IQV
Gross Profit
$5.2B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
15%

See Also

What is MaxCyte Inc's Gross Profit?
Gross Profit
36.5m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Gross Profit amounts to 36.5m USD.

What is MaxCyte Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
20%

Over the last year, the Gross Profit growth was -7%. The average annual Gross Profit growth rates for MaxCyte Inc have been 16% over the past three years , 20% over the past five years .